Education
About Us
Working with TipRanks
Follow Us
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 118.71M | $ 124.96M | $ 152.07M | $ 156.23M | $ 111.01M |
| Gross Profit | $ 83.33M | $ 85.73M | $ 125.05M | $ 137.49M | $ 95.18M |
| Operating Income | $ -21.54M | $ -24.48M | $ -243.54M | $ 39.41M | $ 9.42M |
| EBITDA | $ 16.32M | $ 5.15M | $ 53.17M | $ 90.17M | $ 38.78M |
| Net Income | $ -29.50M | $ -21.58M | $ -331.94M | $ 109.63M | $ -1.28M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 63.41M | $ 100.05M | $ 73.44M | $ 64.94M | $ 36.81M |
| Total Assets | $ 266.97M | $ 284.73M | $ 286.42M | $ 413.91M | $ 326.55M |
| Total Debt | $ 39.12M | $ 40.27M | $ 39.68M | $ 66.87M | $ 75.87M |
| Net Debt | $ 28.89M | $ -10.32M | $ -33.77M | $ 1.93M | $ 39.06M |
| Total Liabilities | $ 173.02M | $ 163.65M | $ 148.42M | $ 188.19M | $ 224.13M |
| Stockholders' Equity | $ 93.95M | $ 121.08M | $ 138.00M | $ 225.72M | $ 102.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -28.18M | $ 26.41M | $ 48.98M | $ 78.32M | $ 5.47M |
| Operating Cash Flow | $ -28.18M | $ 26.41M | $ 49.60M | $ 78.60M | $ 5.52M |
| Investing Cash Flow | $ -11.99M | $ -48.91M | $ 3.10M | $ -42.67M | $ -18.52M |
| Financing Cash Flow | $ -189.00K | $ -350.00K | $ -44.20M | $ -7.79M | $ 29.03M |